APVO · Aptevo Therapeutics Inc. · Executive Compensation
$1.80
+0.04 (+2.27%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“When considered in aggregate, these factors raise substantial doubt about our ability to continue as a going concern for the one-year period from the date of issuance of these financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$3.39M
Shares
1.80M
Volume · Oct 5
28.1K
Avg daily vol (3M)
111.65K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Marvin L. White | President and Chief Executive Officer | $1,277,403 |
| Jeffrey G. Lamothe | Executive Vice President and Chief Operating Officer | $1,020,205 |
| SoYoung Kwon | Senior Vice President, General Counsel, Business Development and Corporate Affairs | $904,464 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Marvin L. White | Chief Executive Officer and President | $974,052 |
| Jeffrey G. Lamothe | Senior Vice President and Chief Financial Officer | $641,192 |
| Jane Gross | Senior Vice President and Chief Scientific Officer | $587,949 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Marvin L. White | Chief Executive Officer and President | $1,104,819 |
| Jeffrey G. Lamothe | Senior Vice President and Chief Financial Officer | $691,987 |
| Jane Gross | Senior Vice President and Chief Scientific Officer | $636,446 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| John E. Niederhuber | Lead Independent Director | Appointed | 2026-02-03 |
| Jeff Lamothe | Class III director | Appointed | 2026-02-03 |
| Jeff Lamothe | President and Chief Executive Officer | Appointed | 2026-02-03 |
| Marvin L. White | Executive Chair of the Board | Appointed | 2026-02-03 |
| Marvin L. White | President and Chief Executive Officer | Retired | 2026-02-03 |
| Daphne Taylor | Senior Vice President, Chief Financial Officer | Appointed | 2023-03-07 |
| Jeffrey G. Lamothe | Executive Vice President, Chief Operating Officer | Appointed | 2023-03-07 |